January 26, 2024Open Access

Early apixaban administration considering the size of infarction and functional outcome in acute ischemic stroke

MLMin Hwan LeeUniversity of California, Merced JKJaseong KooLI-COR Biosciences (United States)HKHanim KwonKorea University

Structured PICO

Does early initiation of apixaban tailored to infarct size improve functional outcomes in patients with acute ischemic stroke?

Population

Patients with acute ischemic stroke

Intervention

Early initiation of apixaban tailored to infarct size

Outcome

Functional outcomeshard clinical

Early initiation of apixaban tailored to infarct size may improve functional outcomes and reduce stroke progression in acute ischemic stroke without increasing bleeding risk.

Abstract

Our findings suggest that early initiation of apixaban, tailored to infarct size, could serve as a viable strategy to enhance functional outcomes. This approach may potentially decrease stroke progression and early recurrence without elevating the risk of sHT.

AIに質問

Bookmark

View Full Paper

Cite This Study

Lee et al. (Fri,) studied this question.

synapsesocial.com/papers/69d5721975589c71d767e4cb https://doi.org/https://doi.org/10.3389/fneur.2024.1302738

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AIに質問

Bookmark

View Full Paper